Share Name Share Symbol Market Type Share ISIN Share Description
Levrett LSE:LVRT London Ordinary Share GB00BYW79Y38 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 3.50p 0.00p 0.00p - - - 0 06:33:49
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -0.7 -0.7 - 3.35

Levrett Share Discussion Threads

Showing 226 to 246 of 250 messages
Chat Pages: 10  9  8  7  6  5  4  3  2  1
DateSubjectAuthorDiscuss
13/10/2017
14:14
Confirmation of Nuformix reverse t/o RNS just now. Trading in new co's shares next week - a long wait but worth it.
maytrees
03/10/2017
09:09
Figures crossed then jimduggen!
maytrees
02/10/2017
20:33
Low free float maytrees. Could fly up to 8 to 10p on open.
jimduggen
02/10/2017
16:16
Many tx jimduggen The nuformix website also sounds positive as one might expect of course, stating: Nuformix is delighted to announce that Levrett plc, a Company formed to acquire a target company in the pharmaceutical and biotechnology sector, has entered into a conditional agreement to acquire the entire issued share capital of Nuformix Limited. Nuformix Chief Executive Officer Dr Dan Gooding said: “The Nuformix team is delighted to reach agreement on the Acquisition. We are proud of our intellectual property portfolio and believe that our two lead cocrystal programmes offer great commercial and therapeutic promise. We see considerable benefits in becoming a listed company and the funds raised through this placing will facilitate the clinical development of NXP001 and NXP002. Cocrystal technology allows us to uniquely and robustly protect, enable and differentiate the resulting products. We’ll continue to add toour IP portfolio and pre-clinical validation also funded by the placing will support future entries to the Nuformix pipeline.”
maytrees
27/9/2017
12:33
hxxp://www.michelmores.com/news-views/news/michelmores-acts-reverse-takeover-standard-listed-levrett-plc-nuformix Will be called nuformix and will open at 4p
jimduggen
24/9/2017
13:47
On a practical note given the shares issued at 4p I would expect the new co's shares to be at that sort of share price when trading starts. Presumably though there will also be a co name change.
maytrees
15/9/2017
17:15
Emend Aprepitant (Emend®) Merck is the global pharma company Wow
jimduggen
15/9/2017
15:38
My reading is also that the new shares of the combined co will be tradable, ie suspension ended in practice, in a months time: "Should the Proposal be approved at the Company's General Meeting and the Acquisition and Placing completed, it is expected that the existing listing on the standard listing segment of the Official List and trading in the Existing Ordinary Shares on the London Stock Exchange's Main Market, will be cancelled at 8.00 a.m. on 16 October 2017 and the Re-Admission is expected to become effective and dealings in the Ordinary Shares to commence on the London Stock Exchange at 8.00 a.m. on 16 October 2017. Further details of the Acquisition and Placing, as well as the Notice of General Meeting to approve the Waiver are contained in the Appendices to this announcement. Capitalised terms in this announcement are as defined in the Prospectus unless the context otherwise requires."
maytrees
15/9/2017
15:31
Hopefully there are some who are still interested in LVRT. Today's announcement seems positive at least from the headline which reads: "Levrett plc, a Company formed to acquire a target company in the pharmaceutical and biotechnology sector, is pleased to announce that it has entered into a conditional agreement to acquire the entire issued share capital of Nuformix Limited ("Nuformix") for a total consideration of £12,000,000 to be settled through the issuance of new ordinary shares in the Company at a price of 4 pence per share (the "Acquisition"), subject to Shareholders' approval and Re-admission (as defined below). In addition, the Company is today announcing the Placing, under which it has issued 57,500,000 Placing Shares at 4p per share, raising £2.3 million, conditional, inter alia, upon Re-Admission."
maytrees
15/9/2017
15:30
What a fantastic RNS - big things expected of this one
chasingprofits
04/9/2017
08:25
TX thirdmanharry Doubly pleased now that I sold half to take profit b4 the RTO suspension last year. Pretty poor show about the co. - They should now at least issue an RNs to explain or perhaps the RNS will come at de-listing stage in a fortnight - to save money. Great care is obviously needed b4 investing in shell cos.
maytrees
01/9/2017
08:45
Greetings jd Some reward from my remaining investment in LVRT over and above the return of the amount invested would be good. Hopefully re-listing on LSE will give a decent return - eventually.
maytrees
01/9/2017
07:05
Not interested maytrees All im interested in is getting my money back
jimduggen
31/8/2017
16:17
The Times commented a while back that: "The standard list also has a significant advantage over AIM in terms of cost. Without the need to pay for a nominated adviser (or its lawyers), a listing on the standard segment can be less than half of an AIM listing and getting a shell on to the market can cost as little as £90,000." So much to play for yet imho.
maytrees
31/8/2017
15:58
The reference to the lender being able to convert at 4p a share in the above April RNs is also encouraging.
maytrees
31/8/2017
15:56
Re-reading the above is not the idea for the combined group to leave AIM anyway and enter "the standard list"? Is not the "standard list" on the LSE list rather than AIM as: "the Official List, the London Stock Exchange's main market for listed securities, now has two tiers: a Premium Listing, retaining the standards currently applicable to all existing primary listings by UK companies on the Official List; and a new Standard Listing, with less onerous standards." I'm no expert though so dyor!
maytrees
31/8/2017
15:48
The time limit is a year I think jd. There would be an RNS upon delisting if that is the way it goes. Bear in mind the RNS as recently as April 2017: "Levrett, a Company formed to acquire a target company with realisable or developed commercial technologies in the pharmaceutical and biotechnology sector, announces that it has entered into a Convertible Loan Agreement for £200,000 ("Loan") with a private investor. The Loan is for a fixed term of 12 months and carries interest at 9% per annum, which the Lender can elect to convert. The Loan is convertible into new Ordinary Shares in the Company at a price of 4 pence per share ("Conversion"), and following Conversion the Lender will be granted a one-for-one warrant to subscribe for new ordinary shares at 4 pence per share, exercisable for a period of three years from Conversion. Under the terms of the Loan, the Lender will advance the total sum to the Company within three business days. The proceeds from the Loan are to be used for general working capital and to support Nuformix Limited in the short-term pending completion of the potential reverse takeover as announced by the Company on 16 September 2016. The acquisition remains conditional, inter alia, on consent from the UK Listing Authority for the readmission of the combined entity to the Standard List." Even if they do de-list all may not be lost. Last time I tried telephoning though getting through to someone who knew about issues was impossible so I am reluctant to try again. A call is unlikely to make any difference especially as there are only a couple of weeks now to announce the RTO etc or delist - either way an RNS soon in any event.
maytrees
31/8/2017
12:33
Yes maytrees Peed off
jimduggen
31/8/2017
11:09
I have sent an email to the PR/media people so now await their reply. If they are as forthcoming as LVRT then silence will essentially mean dead in the water (all imho).
maytrees
31/8/2017
09:12
Greetings jimduggen Have you truncated some of your posts above? I am now fearing de-listing.
maytrees
29/8/2017
14:22
Nerves at this stage rather than panic jimd. If there had been a failure to agree with Nuformix that would have warranted an RNS. No new RNS probably means all on track though perhaps a non-shell co might have issued an interim RNS before now, to reassure.
maytrees
Chat Pages: 10  9  8  7  6  5  4  3  2  1
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:42 V: D:20171017 13:27:48